| MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF(V600E) : An In Vitro | |
| Cheng, Lingxiao; Cheng, Lin; Liu, Min; Chen, Libo; Fu, Hao; Jin, Yuchen | |
| 刊名 | MOLECULAR THERAPY-ONCOLYTICS
 |
| 2019 | |
| 卷号 | 12 |
| ISSN号 | 2372-7705 |
| URL标识 | 查看原文 |
| 语种 | 英语 |
| 内容类型 | 期刊论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3594766 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Cheng, Lingxiao,Cheng, Lin,Liu, Min,et al. MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF(V600E) : An In Vitro[J]. MOLECULAR THERAPY-ONCOLYTICS,2019,12. |
| APA | Cheng, Lingxiao,Cheng, Lin,Liu, Min,Chen, Libo,Fu, Hao,&Jin, Yuchen.(2019).MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF(V600E) : An In Vitro.MOLECULAR THERAPY-ONCOLYTICS,12. |
| MLA | Cheng, Lingxiao,et al."MAPK Inhibitors Enhance HDAC Inhibitor-Induced Redifferentiation in Papillary Thyroid Cancer Cells Harboring BRAF(V600E) : An In Vitro".MOLECULAR THERAPY-ONCOLYTICS 12(2019). |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论